The role of tumor microenvironment in cancer metastasis: Molecular mechanisms and therapeutic opportunities

CM Neophytou, M Panagi, T Stylianopoulos… - Cancers, 2021 - mdpi.com
Simple Summary Metastasis, the process by which cancer cells escape primary tumor site
and colonize distant organs, is responsible for most cancer-related deaths. The tumor …

Extracellular matrix structure

AD Theocharis, SS Skandalis, C Gialeli… - Advanced drug delivery …, 2016 - Elsevier
Extracellular matrix (ECM) is a non-cellular three-dimensional macromolecular network
composed of collagens, proteoglycans/glycosaminoglycans, elastin, fibronectin, laminins …

Improving drug delivery to solid tumors: priming the tumor microenvironment

IA Khawar, JH Kim, HJ Kuh - Journal of Controlled Release, 2015 - Elsevier
Malignant transformation and growth of the tumor mass tend to induce changes in the
surrounding microenvironment. Abnormality of the tumor microenvironment provides a …

[HTML][HTML] From antimicrobial to anticancer peptides. A review

D Gaspar, AS Veiga, MARB Castanho - Frontiers in microbiology, 2013 - frontiersin.org
Antimicrobial peptides (AMPs) are part of the innate immune defense mechanism of many
organisms. Although AMPs have been essentially studied and developed as potential …

Cancer treatment using peptides: current therapies and future prospects

J Thundimadathil - Journal of amino acids, 2012 - Wiley Online Library
This paper discusses the role of peptides in cancer therapy with special emphasis on
peptide drugs which are already approved and those in clinical trials. The potential of …

A systems biology view of blood vessel growth and remodelling

EA Logsdon, SD Finley, AS Popel… - Journal of cellular and …, 2014 - Wiley Online Library
Blood travels throughout the body in an extensive network of vessels–arteries, veins and
capillaries. This vascular network is not static, but instead dynamically remodels in response …

Druggable protein–protein interactions–from hot spots to hot segments

N London, B Raveh, O Schueler-Furman - Current opinion in chemical …, 2013 - Elsevier
Highlights•PPIs that are dominated by a continuous epitope are amenable for inhibition.•A
significant share of PPIs contains such 'hot segments'.•Peptide-based inhibitors are obvious …

Transformable peptide nanocarriers for expeditious drug release and effective cancer therapy via cancer‐associated fibroblast activation

T Ji, Y Zhao, Y Ding, J Wang, R Zhao… - Angewandte Chemie …, 2016 - Wiley Online Library
A novel cleavable amphiphilic peptide (CAP) was designed to be specifically responsive to
fibroblast activation protein‐α (FAP‐α), a protease specifically expressed on the surface of …

[HTML][HTML] Pharmacologic therapies in endometriosis: a systematic review

SR Soares, A Martínez-Varea, JJ Hidalgo-Mora… - Fertility and sterility, 2012 - Elsevier
To assess the literature on preclinical and clinical efficacy and safety data of pharmacologic
groups proposed in the treatment of endometriosis, we performed a systematic review of …

Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directions

Z Lin, Q Zhang, W Luo - European journal of pharmacology, 2016 - Elsevier
Angiogenesis has become an attractive target for cancer therapy since the US Food and
Drug Administration (FDA) approved the first angiogenesis inhibitor (bevacizumab) for the …